Using mobile units to provide medication for opioid use disorder in New York.
Implementation of Mobile Medication Units for Patients with Opioid Use Disorder in New York.
This study is looking at how mobile units that provide methadone can help people with opioid use disorder in New York get the treatment they need more easily, especially if they have trouble reaching regular clinics, and it will share what works and what doesn’t to help similar programs in other places.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10931624 on NIH RePORTER |
What this research studies
This research investigates the implementation of mobile medication units that dispense methadone for patients with opioid use disorder (OUD) in New York. By utilizing mobile units, the project aims to improve access to treatment for individuals who face barriers in reaching traditional opioid treatment programs. The study will explore the challenges and successes of launching these mobile units, which could also offer additional services like counseling. The findings will help inform similar initiatives in other states during the ongoing national overdose crisis.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with opioid use disorder who have difficulty accessing traditional treatment facilities.
Not a fit: Patients who are not diagnosed with opioid use disorder or those who have access to traditional treatment programs may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve access to life-saving medication and support services for individuals struggling with opioid use disorder.
How similar studies have performed: Other research has shown promise in expanding access to treatment through mobile units, indicating that this approach could be effective.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Saloner, Brendan K — Johns Hopkins University
- Study coordinator: Saloner, Brendan K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.